TrimRx's Blog
Amycretin vs Retatrutide: How Two Next-Generation Weight Loss Drugs Compare
Amycretin and retatrutide are two of the most closely watched experimental obesity drugs in development, and they come from the two companies that already…
Survodutide vs Retatrutide: Dual vs Triple Agonist
Survodutide and retatrutide are both investigational obesity drugs that add glucagon to GLP-1, but retatrutide goes a step further by also targeting GIP. Neither…
Retatrutide vs CagriSema: How the Two Next-Gen Drugs Compare
Retatrutide and CagriSema are both investigational obesity drugs that outperform current medications in trials, and neither is FDA approved or available by prescription, from…
What Is Amycretin? The Next-Generation GLP-1 and Amylin Drug
Amycretin stands out for an unusual reason: it is one of the few high-efficacy obesity drugs being developed as both a weekly injection and…
CagriSema vs Wegovy: How They Compare
CagriSema and Wegovy share an active ingredient, which makes this an unusually direct comparison. CagriSema is Wegovy’s semaglutide plus a second drug, the amylin…
CagriSema vs Zepbound: How They Compare
If you are weighing CagriSema against Zepbound, the most important fact is availability: Zepbound (tirzepatide) is FDA approved and you can start it now,…
What Is CagriSema? The Semaglutide-Amylin Combination Explained
CagriSema is an investigational once-weekly injection from Novo Nordisk that combines two drugs in a single shot: semaglutide (the GLP-1 medication in Wegovy and…
Retatrutide Half-Life: How Long It Stays in Your System
Retatrutide has a half-life of about six days. That single number explains a lot: it is why the drug is injected once a week,…
Retatrutide Benefits Beyond Weight Loss: What the Trials Show
Weight loss gets the headlines, but in clinical trials retatrutide has shown effects that reach well past the scale: better blood sugar, less liver…
